Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00340483 · ClinicalTrials.gov registry record · Phase 1

Smoking Cessation Aid for Young Smokers

A Phase 1 study, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).

Completed
Registry status
Phase 1
Development phase
291
Enrollment target

NCT00340483 is a Phase 1 study that has completed, run by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). The registered enrollment target is 291 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00340483, a Phase 1 study, has completed, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).

COMPLETED
Registry status
Phase 1
Development phase
291 participants
Enrollment target

Study Summary

This study, sponsored jointly by the George Washington University School of Public Health and the NICHD, will compare the effectiveness of two self-help quit-smoking programs for young people. Smokers between 18 and 22 years of age who are interested in quitting smoking may be eligible for this 6-month study. Candidates must be enrolled in school at least part time. Participants are randomly assigned to one of two treatment groups. Both groups receive a brief counseling session and self-help guide, and one group also receives email counseling related to quitting smoking. All participants have three interviews-one in person at the beginning of the program, one over the phone after 2 months in the program, and one in person after 6 months, at the end of the program. The surveys cover the participant's intentions and behaviors related to smoking cessation and their opinions about the self-help materials. In addition, participants may be asked to provide saliva samples at the beginning and end of the program for verifying smoking status.

Interventions

  • BEHAVIORAL Smoking cessation

Trial Details

FieldValue
Enrollment Target 291 participants
Start Date 2004-05-25
Est. Completion 2006-12-14
Phase Phase 1

What the Registry Record Tells You About NCT00340483

The ClinicalTrials.gov registry entry for NCT00340483 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 291 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), which has 305 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Smoking cessation is the first listed.

NCT00340483 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00340483 about?

NCT00340483 is a clinical study titled "Smoking Cessation Aid for Young Smokers". This study, sponsored jointly by the George Washington University School of Public Health and the NICHD, will compare the effectiveness of two self-help quit-smoking programs for young people. Smokers between 18 and 22 years of age who are interested in quitting smoking may be eligible for this 6-m...

What is the current status of trial NCT00340483?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 291 participants. The study started on 2004-05-25. Estimated completion is 2006-12-14.

What interventions are being tested in trial NCT00340483?

The interventions under investigation include: Smoking cessation (BEHAVIORAL).

Who is sponsoring clinical trial NCT00340483?

This trial is sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), which has 305 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.